Syncona Portfolio LTD Freeline Therapeutics Holdings PLC Transaction History

Syncona Portfolio LTD

  • $80.7 Million
  • Q3 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2023

Nov 01, 2023
SELL
$2.53 - $5.75 $2 - $5
-1 Reduced -0.0%
1,466,507 $6.31 Million
Q2 2023

Jul 27, 2023
SELL
$0.24 - $3.33 $4.93 Million - $68.4 Million
-20,531,112 Reduced 93.33%
1,466,508 $3.78 Million
Q1 2022

May 31, 2022
BUY
$0.92 - $2.03 $17.5 Million - $38.7 Million
19,047,620 Added 645.68%
21,997,620 $5.84 Million
Q4 2021

Feb 11, 2022
BUY
$1.97 - $3.45 $5.81 Million - $10.2 Million
2,950,000 New
2,950,000 $5.84 Million

Others Institutions Holding FRLN

# of Institutions
1
Shares Held
30.1K
Call Options Held
0
Put Options Held
0
View Full List

About Freeline Therapeutics Holdings plc

FRLN Quotes by TradingView
  • Ticker FRLN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 64,972,300
  • Description
  • Freeline Therapeutics Holdings plc, a clinical-stage biotechnology company, develops transformative adeno-associated virus (AAV) vector-mediated gene therapies for patients suffering from inherited systemic debilitating diseases. Its advanced product candidate is verbrinacogene setparvovec (FLT180a), a gene therapy product candidate that is in P...
More about FRLN
Track This Portfolio

Track Syncona Portfolio LTD Portfolio

Follow Syncona Portfolio LTD and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Syncona Portfolio LTD, based on Form 13F filings with the SEC.

News

Stay updated on Syncona Portfolio LTD with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email